Bimatoprost Versus Travoprost in an Egyptian Population: A Hospital-Based Prospective Randomized Study.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 试验地点
- 1
- 主要终点
- Percentage of intraocular pressure lowering of bimatoprost versus travoprost.
研究概览
简要总结
Bimatoprost has been shown to provide effective IOP lowering in patients of all races. Conversely, travoprost has been shown to be more effective in black patients than in Caucasians in some studies. However, Noecker et al 2004 compared bimatoprost with travoprost in African-Americans with glaucoma or OHT, and found that bimatoprost was more likely than travoprost to achieve target pressure at 3 months.
These racial differences in efficacy of these medications warrant further investigations. The investigators study aim to compare the IOP-lowering efficacies of bimatoprost and travoprost in an Egyptian population with primary open-angle glaucoma (OAG) or ocular hypertension (OHT).
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 72 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Glaucoma and Ocular Hypertension
排除标准
- •Any ocular disease or medication that may raise the intraocular pressure.
结局指标
主要结局
Percentage of intraocular pressure lowering of bimatoprost versus travoprost.
次要结局
- Rate of development of complications.